• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制Rho激酶可诱导小梁网细胞产生抗氧化分子并抑制活性氧。

Inhibition of Rho Kinase Induces Antioxidative Molecules and Suppresses Reactive Oxidative Species in Trabecular Meshwork Cells.

作者信息

Fujimoto Tomokazu, Inoue Toshihiro, Ohira Saori, Awai-Kasaoka Nanako, Kameda Takanori, Inoue-Mochita Miyuki, Tanihara Hidenobu

机构信息

Department of Ophthalmology, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan.

Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.

出版信息

J Ophthalmol. 2017;2017:7598140. doi: 10.1155/2017/7598140. Epub 2017 Jul 19.

DOI:10.1155/2017/7598140
PMID:28804648
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5540245/
Abstract

PURPOSE

To investigate the effect of rho kinase inhibitors on oxidative stress in trabecular meshwork (TM) cells.

METHODS

TM cells were isolated from the eyes of cynomolgus monkeys. Y-27632 and menadione were used to inhibit rho kinase and induce production of reactive oxygen species (ROS), respectively. The cynomolgus monkey array and 12,613 probes were used in DNA microarray analysis, and the affected genes were categorized using gene ontology analysis. The mRNA levels of the target genes were confirmed by real-time RT-PCR. Intracellular oxidative stress was detected using a fluorescent reagent sensitive to ROS. Cell viability was assessed by the WST-8 assay.

RESULTS

Gene ontology analysis revealed upregulation of genes involved in antioxidant activity, and upregulation of catalase was confirmed by real-time RT-PCR after 30 min treatment with Y-27632. Production of ROS was increased by menadione, and the effect was partly suppressed by pretreatment with Y-27632. At a lower dose of menadione, Y-27632 stimulated TM cells and significantly increased their viability following menadione treatment compared to control cells.

CONCLUSION

Using microarray analysis, Y-27632 was shown to upregulate antioxidative genes including catalase and partially reduce ROS production and cell death by oxidative stress caused by menadione.

摘要

目的

研究Rho激酶抑制剂对小梁网(TM)细胞氧化应激的影响。

方法

从食蟹猴眼中分离出TM细胞。分别使用Y-27632和甲萘醌抑制Rho激酶并诱导活性氧(ROS)的产生。在DNA微阵列分析中使用食蟹猴基因芯片和12,613个探针,并通过基因本体分析对受影响的基因进行分类。通过实时逆转录聚合酶链反应(RT-PCR)确认靶基因的mRNA水平。使用对ROS敏感的荧光试剂检测细胞内氧化应激。通过WST-8法评估细胞活力。

结果

基因本体分析显示参与抗氧化活性的基因上调,在用Y-27632处理30分钟后,通过实时RT-PCR证实过氧化氢酶上调。甲萘醌增加了ROS的产生,而Y-27632预处理部分抑制了该作用。在较低剂量的甲萘醌作用下,与对照细胞相比,Y-27632刺激TM细胞并在甲萘醌处理后显著提高其活力。

结论

通过微阵列分析表明,Y-27632可上调包括过氧化氢酶在内的抗氧化基因,并部分减少由甲萘醌引起的氧化应激导致的ROS产生和细胞死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe97/5540245/13e797f9bd22/JOPH2017-7598140.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe97/5540245/914c43d5a0ba/JOPH2017-7598140.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe97/5540245/13e797f9bd22/JOPH2017-7598140.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe97/5540245/914c43d5a0ba/JOPH2017-7598140.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe97/5540245/13e797f9bd22/JOPH2017-7598140.002.jpg

相似文献

1
Inhibition of Rho Kinase Induces Antioxidative Molecules and Suppresses Reactive Oxidative Species in Trabecular Meshwork Cells.抑制Rho激酶可诱导小梁网细胞产生抗氧化分子并抑制活性氧。
J Ophthalmol. 2017;2017:7598140. doi: 10.1155/2017/7598140. Epub 2017 Jul 19.
2
Effects of the Rho kinase inhibitor Y-27632 and the phosphatase inhibitor calyculin A on outflow facility in monkeys.Rho激酶抑制剂Y-27632和磷酸酶抑制剂花萼海绵诱癌素A对猴眼房水流畅系数的影响。
Exp Eye Res. 2005 Feb;80(2):215-25. doi: 10.1016/j.exer.2004.09.002.
3
Mitochondrial complex I defect induces ROS release and degeneration in trabecular meshwork cells of POAG patients: protection by antioxidants.线粒体复合体I缺陷诱导开角型青光眼患者小梁网细胞中活性氧的释放和退变:抗氧化剂的保护作用
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1447-58. doi: 10.1167/iovs.07-1361.
4
Comparative Study of the Effects of Trabecular Meshwork Outflow Drugs on the Permeability and Nitric Oxide Production in Trabecular Meshwork Cells.小梁网流出药物对小梁网细胞通透性和一氧化氮生成影响的比较研究
Korean J Ophthalmol. 2017 Oct;31(5):452-459. doi: 10.3341/kjo.2017.0020. Epub 2017 Jul 25.
5
Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues.前列腺素类似物可减轻小梁网细胞中氧化应激的影响。
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4872-80. doi: 10.1167/iovs.07-0984.
6
Contribution of ROCK in contraction of trabecular meshwork: proposed mechanism for regulating aqueous outflow in monkey and human eyes.ROCK在小梁网收缩中的作用:调节猴眼和人眼房水流出的潜在机制
J Pharm Sci. 2005 Apr;94(4):701-8. doi: 10.1002/jps.20285.
7
Differential amplification of gene expression in lens cell lines conditioned to survive peroxide stress.在适应过氧化物应激存活的晶状体细胞系中基因表达的差异扩增。
Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3251-64.
8
Sustained stress response after oxidative stress in trabecular meshwork cells.小梁网细胞氧化应激后的持续应激反应。
Mol Vis. 2007 Dec 17;13:2282-8.
9
Rho-associated protein kinase inhibitor, Y-27632, induces alterations in adhesion, contraction and motility in cultured human trabecular meshwork cells.Rho相关蛋白激酶抑制剂Y-27632可诱导培养的人小梁网细胞的黏附、收缩和运动发生改变。
Exp Eye Res. 2006 Mar;82(3):362-70. doi: 10.1016/j.exer.2005.07.006. Epub 2005 Aug 25.
10
Mitochondria-targeted peptide MTP-131 alleviates mitochondrial dysfunction and oxidative damage in human trabecular meshwork cells.线粒体靶向肽 MTP-131 可减轻人眼小梁细胞中线粒体功能障碍和氧化损伤。
Invest Ophthalmol Vis Sci. 2011 Sep 1;52(10):7027-37. doi: 10.1167/iovs.11-7524.

引用本文的文献

1
Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment.青光眼治疗中的免疫调节和抗氧化药物
Pharmaceuticals (Basel). 2023 Aug 22;16(9):1193. doi: 10.3390/ph16091193.
2
Oxidative Stress: A Suitable Therapeutic Target for Optic Nerve Diseases?氧化应激:视神经疾病的合适治疗靶点?
Antioxidants (Basel). 2023 Jul 20;12(7):1465. doi: 10.3390/antiox12071465.
3
A ROCK inhibitor suppresses the transforming growth factor-beta-2-induced endothelial-mesenchymal transition in Schlemm's canal endothelial cells.一种 ROCK 抑制剂抑制转化生长因子-β2 诱导的小梁网内皮细胞向间充质细胞的转化。

本文引用的文献

1
ROCK inhibition as a potential therapeutic target involved in apoptosis in hemangioma.ROCK抑制作为血管瘤凋亡潜在的治疗靶点。
Oncol Rep. 2017 May;37(5):2987-2993. doi: 10.3892/or.2017.5515. Epub 2017 Mar 21.
2
Correlation between Systemic Oxidative Stress and Intraocular Pressure Level.全身氧化应激与眼压水平之间的相关性
PLoS One. 2015 Jul 17;10(7):e0133582. doi: 10.1371/journal.pone.0133582. eCollection 2015.
3
Aqueous humor outflow: dynamics and disease.房水流出:动力学与疾病
Sci Rep. 2023 Jun 14;13(1):9655. doi: 10.1038/s41598-023-36808-8.
4
The Intertwined Roles of Oxidative Stress and Endoplasmic Reticulum Stress in Glaucoma.氧化应激与内质网应激在青光眼中的交织作用
Antioxidants (Basel). 2022 Apr 29;11(5):886. doi: 10.3390/antiox11050886.
5
Enhanced RAGE Expression and Excess Reactive-Oxygen Species Production Mediates Rho Kinase-Dependent Detrusor Overactivity After Methylglyoxal Exposure.甲基乙二醛暴露后,增强的晚期糖基化终末产物受体(RAGE)表达和过量的活性氧生成介导了 Rho 激酶依赖性逼尿肌过度活动。
Front Physiol. 2022 Mar 28;13:860342. doi: 10.3389/fphys.2022.860342. eCollection 2022.
6
Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma.用于治疗青光眼的研究性 Rho 激酶抑制剂
J Exp Pharmacol. 2021 Feb 25;13:197-212. doi: 10.2147/JEP.S259297. eCollection 2021.
7
[Rho kinase inhibitors as new local therapy option in primary open angle glaucoma].[ Rho激酶抑制剂作为原发性开角型青光眼的新型局部治疗选择]
Ophthalmologe. 2021 May;118(5):449-460. doi: 10.1007/s00347-020-01303-2. Epub 2021 Jan 5.
8
Oxidative stress and antioxidants in the trabecular meshwork.小梁网中的氧化应激与抗氧化剂
PeerJ. 2019 Nov 26;7:e8121. doi: 10.7717/peerj.8121. eCollection 2019.
9
Rho kinase inhibitors-a review on the physiology and clinical use in Ophthalmology.Rho激酶抑制剂——眼科生理学及临床应用综述
Graefes Arch Clin Exp Ophthalmol. 2019 Jun;257(6):1101-1117. doi: 10.1007/s00417-019-04283-5. Epub 2019 Mar 7.
10
Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date.奈他地尔滴眼液的概况及其在开角型青光眼治疗中的潜力:迄今的证据
Clin Ophthalmol. 2018 Oct 4;12:1939-1944. doi: 10.2147/OPTH.S154001. eCollection 2018.
Invest Ophthalmol Vis Sci. 2015 May;56(5):2993-3003. doi: 10.1167/iovs.15-16744.
4
Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials.Rho 激酶抑制剂 ripasudil(K-115)联合噻吗洛尔或拉坦前列素的降眼压相加作用:两项随机临床试验报告。
JAMA Ophthalmol. 2015 Jul;133(7):755-61. doi: 10.1001/jamaophthalmol.2015.0525.
5
Extracellular matrix in the trabecular meshwork: intraocular pressure regulation and dysregulation in glaucoma.小梁网中的细胞外基质:青光眼患者的眼压调节与调节异常
Exp Eye Res. 2015 Apr;133:112-25. doi: 10.1016/j.exer.2014.07.014.
6
p38 MAP kinase inhibitor suppresses transforming growth factor-β2-induced type 1 collagen production in trabecular meshwork cells.p38丝裂原活化蛋白激酶抑制剂抑制转化生长因子-β2诱导的小梁网细胞中I型胶原蛋白的产生。
PLoS One. 2015 Mar 23;10(3):e0120774. doi: 10.1371/journal.pone.0120774. eCollection 2015.
7
Ripasudil: first global approval.利匹司他:全球首次批准。
Drugs. 2014 Dec;74(18):2211-5. doi: 10.1007/s40265-014-0333-2.
8
The novel Rho kinase (ROCK) inhibitor K-115: a new candidate drug for neuroprotective treatment in glaucoma.新型 Rho 激酶(ROCK)抑制剂 K-115:青光眼神经保护治疗的新候选药物。
Invest Ophthalmol Vis Sci. 2014 Oct 2;55(11):7126-36. doi: 10.1167/iovs.13-13842.
9
Evaluation of oxidative stress markers in aqueous humor of primary open angle glaucoma and primary angle closure glaucoma patients.原发性开角型青光眼和原发性闭角型青光眼患者房水中氧化应激标志物的评估。
Curr Eye Res. 2014 Aug;39(8):823-9. doi: 10.3109/02713683.2011.556299. Epub 2014 Jun 9.
10
Oxidative damage impact on aging and age-related diseases: drug targeting of telomere attrition and dynamic telomerase activity flirting with imidazole-containing dipeptides.氧化损伤对衰老及与年龄相关疾病的影响:针对端粒损耗和动态端粒酶活性的药物靶向作用与含咪唑二肽的关联
Recent Pat Drug Deliv Formul. 2014;8(3):163-92. doi: 10.2174/1872211308666140602125505.